BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, December 23, 2025
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for Nov. 3, 2025

Nov. 3, 2025
Clinical updates, including data readouts and publications: Astrazeneca, Boost, Celldex, Hightide, Karolinska, Parabilis, Stallergenes Greer, Vesper.
Read More

In the clinic for Oct. 31, 2025

Oct. 31, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biostem Technologies.
Read More

In the clinic for Oct. 31, 2025

Oct. 31, 2025
Clinical updates, including data readouts and publications: Argenx, Avobis, Dianthus, Innocare, Johnson & Johnson, Neutrolis, Novartis, Tectonic, Unicycive, Vor, Wave.
Read More

In the clinic for Oct. 30, 2025

Oct. 30, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Humacyte, Recor Medical, Surmodics, Tactile Medical.
Read More

In the clinic for Oct. 30, 2025

Oct. 30, 2025
Clinical updates, including data readouts and publications: Abbvie, Anaptysbio, Bridgebio, Concerto, Eisai, Kyverna, Merck, Sonoma.
Read More

In the clinic for Oct. 29, 2025

Oct. 29, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Anteris, Fastwave, Philips, Sweetch Health, Theranica Bio-Electronics.
Read More

In the clinic for Oct. 29, 2025

Oct. 29, 2025
Clinical updates, including data readouts and publications: Aldeyra, Ardelyx, Ayrmid, Causeway, Cingulate, Delix, Edesa, Ferring, Lantern, Lumosa, Merck, Oncolytics, Quoin, Roche, Sudo, Trethera.
Read More

In the clinic for Oct. 28, 2025

Oct. 28, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cardiosense, Medtronic, Mercy Bioanalytics, Natera, Pleural Dynamics, Smith+Nephew.
Read More

In the clinic for Oct. 28, 2025

Oct. 28, 2025
Clinical updates, including data readouts and publications: BMS, Bridgebio, Cabaletta, Cristcot, Halda, Innovent, Intellia, ITM, Kyverna, J&J, Levicept, Sobi, Xencor, Zenas.
Read More

In the clinic for Oct. 28, 2025

Oct. 28, 2025
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Advancell Isotopes, Astellas, Entera Bio, Harbour Biomed, Iaso Biotherapeutics, Metis Techbio, Rapt Therapeutics, Sagimet Biosciences.
Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 12 … 310 311 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 22, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 22, 2025.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing